F
$ Value
$25K
Shares
36,418
Price
$1
Filed
Mar 26
Insider
Name
Berg Edward B
Title
SVP, General Counsel
CIK
0001912178
Roles
Officer
Transaction Details
Transaction Date
2026-03-24
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
755,368
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 24, 2026. | This amount includes 70,781 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.
Filing Info
Berg Edward B's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | VXRT | F | $25K |
| 2026-03-18 | VXRT | F | $5K |
| 2026-03-16 | VXRT | A | $0 |
| 2026-03-16 | VXRT | A | $0 |
| 2026-02-02 | VXRT | F | $6K |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-18 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |